- 2022 - 2025 胆道癌におけるChemokineによる悪性度進行機構の解明
- 2020 - 2023 Research on the mutual paracrine effect by MMP-9 and sCD154 between CD40 positive ESCC cells and platelets
- 2020 - 2023 ゲノム・遺伝子変異プロファイル解析を用いた膵癌における新規治療戦略の構築
- 2019 - 2022 Development of retroviral replicating vector-mediated prodrug activator gene therapy for biliary tract cancer
- 2018 - 2021 Retroviral replicating vector mediated gene therapy activates anti-tumor immune responses in an immunocompetent pancreatic cancer model
- 2018 - 2021 Development of a new therapeutic method for pancreatic cancer using a cell-penetrating peptide targeting C16orf74
- 2018 - 2021 Retroviral replicating vector-mediated gene therapy for lung cancer
- 2017 - 2020 Development of immunotherapy following curative resection for refractory solid cancers
- 2017 - 2020 Epithelial- Mesenchymal transition and genetic mutation in Lymph node metastasis in extrahepatic cholalngiocarcinoma
- 2016 - 2019 Discovering the biomarkers and development of new therapeutics in pancreatic cancer
- 2014 - 2017 Treatment strategy to prevent postoperative recurrence of cancers by inducing host immune responses following neoadjuvant chemotherapy.
- 2014 - 2017 Retroviral Replicating Vector (RRV)- Mediated Prodrug-Activator Gene Therapy for Pancreatic Cancer
- 2014 - 2017 Inhibition of Eph receptor A4 by 2,5-dimethylpyrrolyl benzoic acid suppresses human pancreatic cancer growing orthotopically in nude mice
- 2013 - 2016 The cell permeable peptide inhibits pancreatic ductal adenocarcinoma cell proliferations and can be used as the molecular targeting dru
- 2011 - 2012 The analysis of the mechanism to induce the tumor specific immune responses by the anti-cancer agents and its clinical utilization
- 2010 - 2012 Identification of the marker for cholangiocarcinoma based on the data by proteomics and tissue microarray
Show all